SCHEMBL8790036

SCHEMBL8790036

CN1C(=O)c2cccnc2N(CCO)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 11/20 0.45
DRD2 P14416 2/20 0.41
HTR6 P50406 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 1/20 0.41
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
MAPT P10636 1/20 0.41
DRD1 P21728 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR7 P34969 1/20 0.41
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790016 0.88 BRD4 (0.47) BRD4DRD2HTR6ALDH1A1LMNA
SCHEMBL8791355 0.86 ALDH1A1 (0.48) BRD4DRD2HTR6ALDH1A1LMNA
SCHEMBL8789567 0.86 BRD4 (0.46) BRD4DRD2HTR6ALDH1A1LMNA
SCHEMBL8791013 0.85 ALDH1A1 (0.48) BRD4ALDH1A1CHRM2MAPTCES1
SCHEMBL11745375 0.84 HRH1 (0.61) BRD4DRD2HTR6LMNACHRM2
SCHEMBL11744491 0.84 BRD4 (0.43) BRD4DRD2HTR6ALDH1A1LMNA
Hydrochloric Acid SCHEMBL11743623 0.83 HRH1 (0.60) BRD4DRD2HTR6LMNACHRM2
SCHEMBL8791147 0.83 BRD4 (0.64) BRD4ALDH1A1MAPTCES1
SCHEMBL8790761 0.82 TTR (0.50) BRD4DRD2HTR6ALDH1A1HTT
SCHEMBL11751843 0.82 CHRM2 (0.46) BRD4DRD2HTR6HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0393604-B1 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMA (US) 1997-12-29 EP disclosed
US-5571809-A The treatment of HIV-1 infection using certain pyridodiazepines BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-11-05 US disclosed
EP-0393604-A2 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1990-10-24 EP disclosed